Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company developing neuroscientific solutions to improve brain health outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. The Company's Brain Network Analytics is a neurophysiological assessment tool that uses artificial intelligence and machine learning to analyze electroencephalogram (EEG) data recorded during rest and cognitive activity. The BNA Platform, in conjunction with an EEG system, provides clinicians with comprehensive insights into brain function (cognition).
BörsenkürzelAIFF
Name des UnternehmensFirefly Neuroscience Inc
IPO-datumOct 27, 1993
Gegründet am2021
CEOMr. Greg Lipschitz
Anzahl der mitarbeiter13
WertpapierartOrdinary Share
GeschäftsjahresendeOct 27
Addresse1100 Military Road
StadtKENMORE
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl14217
Telefon18882376412
Websitehttps://fireflyneuro.com/
BörsenkürzelAIFF
IPO-datumOct 27, 1993
Gegründet am2021
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten